AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

PIROXICAM BETA CYCLODEXTRINE

11 registrations across 2 African markets— 6 active

Markets with PIROXICAM BETA CYCLODEXTRINE

Recent registrations

Brand / ProductMarketHolderStatusExpires
CYCLODEX
Comprimé sécable / 20 mg
🇹🇳TunisiaTERIAKexpiredApr 2017
CYCLODEX
Comprimé sécable / 20 mg
🇹🇳TunisiaTERIAKexpiredNov 2010
CYCLADOL
Suppositoire / 20 MG
🇹🇳TunisiaIBN AL BAYTARexpiredMay 2003
CYCLADOL
Comprimé effervescent / 20 MG
🇹🇳TunisiaCHIESI S.A.SexpiredSept 2001
CYCLADOL
Comprimé sécable / 20 MG
🇹🇳TunisiaCHIESI S.A.SexpiredJun 1997
BREXIN
COMPRIME EFFERVESCENT
🇲🇦Moroccoactive
BREXIN
COMPRIME EFFERVESCENT
🇲🇦Moroccoactive
BREXIN
SUPPOSITOIRE
🇲🇦Moroccoactive
BREXIN
POUDRE POUR SUSPENSION BUVABLE
🇲🇦Moroccoactive
BREXIN
COMPRIME SECABLE
🇲🇦Moroccoactive
BREXIN
SUPPOSITOIRE
🇲🇦Moroccoactive

PIROXICAM BETA CYCLODEXTRINE in Africa — Regulatory Overview

PIROXICAM BETA CYCLODEXTRINE is registered across 2 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco, Tunisia. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 6 (55%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.